Inflammatory Bowel Disease - Pipeline Review, H2 2015

Date: December 31, 2015
Pages: 1025
Price:
US$ 2,000.00 US$ 1,700.00
Offer valid until December 31, 2016!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: IC39B616941EN
Leaflet:

Download PDF Leaflet

Inflammatory Bowel Disease - Pipeline Review, H2 2015

SUMMARY

Global Markets Direct’s, ‘Inflammatory Bowel Disease - Pipeline Review, H2 2015’, provides an overview of the Inflammatory Bowel Disease’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Inflammatory Bowel Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Inflammatory Bowel Disease and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • The report provides a snapshot of the global therapeutic landscape of Inflammatory Bowel Disease
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Inflammatory Bowel Disease and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Inflammatory Bowel Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Inflammatory Bowel Disease pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
REASONS TO BUY
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Inflammatory Bowel Disease
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Inflammatory Bowel Disease pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Introduction
Inflammatory Bowel Disease Overview
Therapeutics Development
Inflammatory Bowel Disease - Therapeutics under Development by Companies
Inflammatory Bowel Disease - Therapeutics under Investigation by Universities/Institutes
Inflammatory Bowel Disease - Pipeline Products Glance
Inflammatory Bowel Disease - Products under Development by Companies
Inflammatory Bowel Disease - Products under Investigation by Universities/Institutes
Inflammatory Bowel Disease - Companies Involved in Therapeutics Development
Inflammatory Bowel Disease - Therapeutics Assessment
Drug Profiles
Inflammatory Bowel Disease - Recent Pipeline Updates
Inflammatory Bowel Disease - Dormant Projects
Inflammatory Bowel Disease - Dormant Projects
Inflammatory Bowel Disease - Discontinued Products
Inflammatory Bowel Disease - Product Development Milestones
Appendix

LIST OF TABLES

Number of Products under Development for Inflammatory Bowel Disease, H2 2015
Number of Products under Development for Inflammatory Bowel Disease - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Development by Companies, H2 2015 (Contd..1)
Number of Products under Development by Companies, H2 2015 (Contd..2)
Number of Products under Development by Companies, H2 2015 (Contd..3)
Number of Products under Development by Companies, H2 2015 (Contd..4)
Number of Products under Development by Companies, H2 2015 (Contd..5)
Number of Products under Development by Companies, H2 2015 (Contd..6)
Number of Products under Development by Companies, H2 2015 (Contd..7)
Number of Products under Development by Companies, H2 2015 (Contd..8)
Number of Products under Development by Companies, H2 2015 (Contd..9)
Number of Products under Development by Companies, H2 2015 (Contd..10)
Number of Products under Development by Companies, H2 2015 (Contd..11)
Number of Products under Development by Companies, H2 2015 (Contd..12)
Number of Products under Development by Companies, H2 2015 (Contd..13)
Number of Products under Development by Companies, H2 2015 (Contd..14)
Number of Products under Development by Companies, H2 2015 (Contd..15)
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Comparative Analysis by Unknown Stage Development, H2 2015
Products under Development by Companies, H2 2015
Products under Development by Companies, H2 2015 (Contd..1)
Products under Development by Companies, H2 2015 (Contd..2)
Products under Development by Companies, H2 2015 (Contd..3)
Products under Development by Companies, H2 2015 (Contd..4)
Products under Development by Companies, H2 2015 (Contd..5)
Products under Development by Companies, H2 2015 (Contd..6)
Products under Development by Companies, H2 2015 (Contd..7)
Products under Development by Companies, H2 2015 (Contd..8)
Products under Development by Companies, H2 2015 (Contd..9)
Products under Development by Companies, H2 2015 (Contd..10)
Products under Development by Companies, H2 2015 (Contd..11)
Products under Development by Companies, H2 2015 (Contd..12)
Products under Development by Companies, H2 2015 (Contd..13)
Products under Development by Companies, H2 2015 (Contd..14)
Products under Development by Companies, H2 2015 (Contd..15)
Products under Development by Companies, H2 2015 (Contd..16)
Products under Development by Companies, H2 2015 (Contd..17)
Products under Development by Companies, H2 2015 (Contd..18)
Products under Development by Companies, H2 2015 (Contd..19)
Products under Development by Companies, H2 2015 (Contd..20)
Products under Development by Companies, H2 2015 (Contd..21)
Products under Development by Companies, H2 2015 (Contd..22)
Products under Development by Companies, H2 2015 (Contd..23)
Products under Development by Companies, H2 2015 (Contd..24)
Products under Development by Companies, H2 2015 (Contd..25)
Products under Development by Companies, H2 2015 (Contd..26)
Products under Investigation by Universities/Institutes, H2 2015
Products under Investigation by Universities/Institutes, H2 2015 (Contd..1)
Inflammatory Bowel Disease - Pipeline by 4D Pharma Plc, H2 2015
Inflammatory Bowel Disease - Pipeline by 4SC AG, H2 2015
Inflammatory Bowel Disease - Pipeline by AB Science SA, H2 2015
Inflammatory Bowel Disease - Pipeline by AbbVie Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Advinus Therapeutics Ltd., H2 2015
Inflammatory Bowel Disease - Pipeline by Aerpio Therapeutics, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Ajinomoto Pharmaceuticals Co., Ltd., H2 2015
Inflammatory Bowel Disease - Pipeline by Akari Therapeutics, Plc, H2 2015
Inflammatory Bowel Disease - Pipeline by Alba Therapeutics Corporation, H2 2015
Inflammatory Bowel Disease - Pipeline by AlbireoPharma, H2 2015
Inflammatory Bowel Disease - Pipeline by Alfa Wassermann S.p.A, H2 2015
Inflammatory Bowel Disease - Pipeline by Allozyne, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Altheus Therapeutics, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Alvine Pharmaceuticals, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Am-Pharma B.V., H2 2015
Inflammatory Bowel Disease - Pipeline by Amakem NV, H2 2015
Inflammatory Bowel Disease - Pipeline by Amgen Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Amorepacific Corporation, H2 2015
Inflammatory Bowel Disease - Pipeline by Ampio Pharmaceuticals, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Amyra Biotech AG, H2 2015
Inflammatory Bowel Disease - Pipeline by Apogee Biotechnology Corporation, H2 2015
Inflammatory Bowel Disease - Pipeline by Ardelyx, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Arena Pharmaceuticals, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Argos Therapeutics, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by AskAt Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Astellas Pharma Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Atlantic Healthcare Plc, H2 2015
Inflammatory Bowel Disease - Pipeline by Avaxia Biologics, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Axxam SpA, H2 2015
Inflammatory Bowel Disease - Pipeline by Basilea Pharmaceutica AG, H2 2015
Inflammatory Bowel Disease - Pipeline by BioAtla, LLC, H2 2015
Inflammatory Bowel Disease - Pipeline by BIOCAD, H2 2015
Inflammatory Bowel Disease - Pipeline by BioLineRx, Ltd., H2 2015
Inflammatory Bowel Disease - Pipeline by BioLingus AG, H2 2015
Inflammatory Bowel Disease - Pipeline by Bionovis SA, H2 2015
Inflammatory Bowel Disease - Pipeline by Biotec Pharmacon ASA, H2 2015
Inflammatory Bowel Disease - Pipeline by BioTherapeutics Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Blueberry Therapeutics Ltd, H2 2015
Inflammatory Bowel Disease - Pipeline by Boehringer Ingelheim GmbH, H2 2015
Inflammatory Bowel Disease - Pipeline by Calypso Biotech SA, H2 2015
Inflammatory Bowel Disease - Pipeline by Catabasis Pharmaceuticals, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Celgene Corporation, H2 2015
Inflammatory Bowel Disease - Pipeline by Cell2B S.A. , H2 2015
Inflammatory Bowel Disease - Pipeline by Cellceutix Corporation, H2 2015
Inflammatory Bowel Disease - Pipeline by Celltrion, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by ChemoCentryx, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by ChironWells GmbH, H2 2015
Inflammatory Bowel Disease - Pipeline by Chong Kun Dang Pharmaceutical Corp., H2 2015
Inflammatory Bowel Disease - Pipeline by CLL Pharma, H2 2015
Inflammatory Bowel Disease - Pipeline by Commence Bio, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Cosmo Pharmaceuticals S.p.A, H2 2015
Inflammatory Bowel Disease - Pipeline by Creabilis SA, H2 2015
Inflammatory Bowel Disease - Pipeline by Cytori Therapeutics, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Daiichi Sankyo Company, Limited, H2 2015
Inflammatory Bowel Disease - Pipeline by DBV Technologies S.A., H2 2015
Inflammatory Bowel Disease - Pipeline by Delenex Therapeutics AG, H2 2015
Inflammatory Bowel Disease - Pipeline by Dr. Falk Pharma GmbH, H2 2015
Inflammatory Bowel Disease - Pipeline by Effimune SAS, H2 2015
Inflammatory Bowel Disease - Pipeline by Eisai Co., Ltd., H2 2015
Inflammatory Bowel Disease - Pipeline by Eli Lilly and Company, H2 2015
Inflammatory Bowel Disease - Pipeline by Eligo Bioscience S.A.S., H2 2015
Inflammatory Bowel Disease - Pipeline by Emergent BioSolutions Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Enceladus Pharmaceuticals BV, H2 2015
Inflammatory Bowel Disease - Pipeline by enGene, Inc, H2 2015
Inflammatory Bowel Disease - Pipeline by Enterome Bioscience SA, H2 2015
Inflammatory Bowel Disease - Pipeline by Enzo Biochem, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Epirus Biopharmaceuticals, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by F. Hoffmann-La Roche Ltd., H2 2015
Inflammatory Bowel Disease - Pipeline by Ferring International Center S.A., H2 2015
Inflammatory Bowel Disease - Pipeline by FibroGen, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Flexion Therapeutics, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Galapagos NV, H2 2015
Inflammatory Bowel Disease - Pipeline by Genentech, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Genfit SA, H2 2015
Inflammatory Bowel Disease - Pipeline by Genor BioPharma Co., Ltd., H2 2015
Inflammatory Bowel Disease - Pipeline by Gilead Sciences, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by GlaxoSmithKline Plc, H2 2015
Inflammatory Bowel Disease - Pipeline by Glenmark Pharmaceuticals Ltd., H2 2015
Inflammatory Bowel Disease - Pipeline by GlycoMar Limited, H2 2015
Inflammatory Bowel Disease - Pipeline by GW Pharmaceuticals Plc, H2 2015
Inflammatory Bowel Disease - Pipeline by iCo Therapeutics Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Idera Pharmaceuticals, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Immune Response BioPharma, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by ImmusanT, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Inbiopro Solutions Pvt. Ltd., H2 2015
Inflammatory Bowel Disease - Pipeline by InDex Pharmaceuticals AB, H2 2015
Inflammatory Bowel Disease - Pipeline by Innate Pharma SA, H2 2015
Inflammatory Bowel Disease - Pipeline by Innovate Biopharmaceuticals, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Innovent Biologics, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by INOXIA Lifesciences GmbH, H2 2015
Inflammatory Bowel Disease - Pipeline by Intas Pharmaceuticals Ltd., H2 2015
Inflammatory Bowel Disease - Pipeline by Intrexon Corporation, H2 2015
Inflammatory Bowel Disease - Pipeline by Invion Limited, H2 2015
Inflammatory Bowel Disease - Pipeline by Jenrin Discovery, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Johnson & Johnson, H2 2015
Inflammatory Bowel Disease - Pipeline by Jyant Technologies, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Kaken Pharmaceutical Co., Ltd., H2 2015
Inflammatory Bowel Disease - Pipeline by Kezar Life Sciences, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Kineta, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Kymab Limited, H2 2015
Inflammatory Bowel Disease - Pipeline by Kyorin Pharmaceutical Co., Ltd., H2 2015
Inflammatory Bowel Disease - Pipeline by Kytogenics Pharmaceuticals, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by La Jolla Pharmaceutical Company, H2 2015
Inflammatory Bowel Disease - Pipeline by Lead Pharma Holding B.V., H2 2015
Inflammatory Bowel Disease - Pipeline by LIPID THERAPEUTICS GmbH, H2 2015
Inflammatory Bowel Disease - Pipeline by Lpath, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by LTT Bio-Pharma Co., Ltd., H2 2015
Inflammatory Bowel Disease - Pipeline by Lycera Corp., H2 2015
Inflammatory Bowel Disease - Pipeline by Mabion SA, H2 2015
Inflammatory Bowel Disease - Pipeline by Mabtech Limited, H2 2015
Inflammatory Bowel Disease - Pipeline by Medestea Research & Production S.p.A., H2 2015
Inflammatory Bowel Disease - Pipeline by Medgenics Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by MedImmune, LLC, H2 2015
Inflammatory Bowel Disease - Pipeline by Merck & Co., Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Mesoblast Limited, H2 2015
Inflammatory Bowel Disease - Pipeline by MetrioPharm AG, H2 2015
Inflammatory Bowel Disease - Pipeline by Mitsubishi Tanabe Pharma Corporation, H2 2015
Inflammatory Bowel Disease - Pipeline by Momenta Pharmaceuticals, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Morphotek, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Mycenax Biotech Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Neovacs SA, H2 2015
Inflammatory Bowel Disease - Pipeline by Nivalis Therapeutics, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Novozymes A/S, H2 2015
Inflammatory Bowel Disease - Pipeline by Ocata Therapeutics, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Omni Bio Pharmaceutical Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Oncobiologics, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Oncodesign SA, H2 2015
Inflammatory Bowel Disease - Pipeline by Opsona Therapeutics Limited, H2 2015
Inflammatory Bowel Disease - Pipeline by Otsuka Holdings Co., Ltd., H2 2015
Inflammatory Bowel Disease - Pipeline by Palatin Technologies, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Pepscan Therapeutics, H2 2015
Inflammatory Bowel Disease - Pipeline by Pfenex Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Pfizer Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Plexxikon Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Pluristem Therapeutics Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Principia Biopharma Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by ProtAb Ltd, H2 2015
Inflammatory Bowel Disease - Pipeline by Protagonist Therapeutics Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Protalix BioTherapeutics, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Provid Pharmaceuticals, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Qu Biologics Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Rebiotix Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Receptos, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by RedHill Biopharma Ltd., H2 2015
Inflammatory Bowel Disease - Pipeline by ReveraGen BioPharma, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Salix Pharmaceuticals Ltd., H2 2015
Inflammatory Bowel Disease - Pipeline by Sandoz International GmbH, H2 2015
Inflammatory Bowel Disease - Pipeline by Saniona AB, H2 2015
Inflammatory Bowel Disease - Pipeline by Sanofi, H2 2015
Inflammatory Bowel Disease - Pipeline by Sareum Holdings Plc, H2 2015
Inflammatory Bowel Disease - Pipeline by SATT Nord, H2 2015
Inflammatory Bowel Disease - Pipeline by Selexys Pharmaceuticals Corporation, H2 2015
Inflammatory Bowel Disease - Pipeline by Seres Therapeutics, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Sigmoid Pharma Limited, H2 2015
Inflammatory Bowel Disease - Pipeline by Sitari Pharmaceuticals, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Soligenix, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Spherium Biomed S.L., H2 2015
Inflammatory Bowel Disease - Pipeline by Stelic Institute & Co., H2 2015
Inflammatory Bowel Disease - Pipeline by sterna biologicals Gmbh & Co KG, H2 2015
Inflammatory Bowel Disease - Pipeline by Sucampo Pharmaceuticals, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Swecure AB, H2 2015
Inflammatory Bowel Disease - Pipeline by Sylentis S.A., H2 2015
Inflammatory Bowel Disease - Pipeline by Synergy Pharmaceuticals, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Synovo GmbH, H2 2015
Inflammatory Bowel Disease - Pipeline by TaiwanJ Pharmaceuticals Co., Ltd., H2 2015
Inflammatory Bowel Disease - Pipeline by Takeda Pharmaceutical Company Limited, H2 2015
Inflammatory Bowel Disease - Pipeline by Teva Pharmaceutical Industries Limited, H2 2015
Inflammatory Bowel Disease - Pipeline by Therapeutic Proteins International, LLC, H2 2015
Inflammatory Bowel Disease - Pipeline by Therapix Biosciences Ltd, H2 2015
Inflammatory Bowel Disease - Pipeline by Theravance Biopharma, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Tillotts Pharma AG, H2 2015
Inflammatory Bowel Disease - Pipeline by Tiziana, H2 2015
Inflammatory Bowel Disease - Pipeline by Tolerys SA, H2 2015
Inflammatory Bowel Disease - Pipeline by Toray Industries, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Torrent Pharmaceuticals Limited, H2 2015
Inflammatory Bowel Disease - Pipeline by Trino Therapeutics Limited, H2 2015
Inflammatory Bowel Disease - Pipeline by UCB S.A., H2 2015
Inflammatory Bowel Disease - Pipeline by Upsher-Smith Laboratories, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Ventria Bioscience, H2 2015
Inflammatory Bowel Disease - Pipeline by VG Life Sciences, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Virobay Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Vitae Pharmaceuticals, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by vTv Therapeutics LLC, H2 2015
Inflammatory Bowel Disease - Pipeline by Winston Pharmaceuticals, Inc., H2 2015
Inflammatory Bowel Disease - Pipeline by Xbrane Bioscience AB, H2 2015
Inflammatory Bowel Disease - Pipeline by Zedira GmbH, H2 2015
Inflammatory Bowel Disease - Pipeline by Zyngenia, Inc., H2 2015
Assessment by Monotherapy Products, H2 2015
Assessment by Combination Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Inflammatory Bowel Disease Therapeutics - Recent Pipeline Updates, H2 2015
Inflammatory Bowel Disease - Dormant Projects, H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..1), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..2), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..3), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..4), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..5), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..6), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..7), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..8), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..9), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..10), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..11), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..12), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..13), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..14), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..15), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..16), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..17), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..18), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..19), H2 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..20), H2 2015 1000
Inflammatory Bowel Disease - Dormant Projects (Contd..21), H2 2015 1001
Inflammatory Bowel Disease - Dormant Projects (Contd..22), H2 2015 1002
Inflammatory Bowel Disease - Dormant Projects (Contd..23), H2 2015 1003
Inflammatory Bowel Disease - Dormant Projects (Contd..24), H2 2015 1004
Inflammatory Bowel Disease - Dormant Projects (Contd..25), H2 2015 1005
Inflammatory Bowel Disease - Dormant Projects (Contd..26), H2 2015 1006
Inflammatory Bowel Disease - Dormant Projects (Contd..27), H2 2015 1007
Inflammatory Bowel Disease - Dormant Projects (Contd..28), H2 2015 1008
Inflammatory Bowel Disease - Dormant Projects (Contd..29), H2 2015 1009
Inflammatory Bowel Disease - Dormant Projects (Contd..30), H2 2015 1010
Inflammatory Bowel Disease - Discontinued Products, H2 2015 1011
Inflammatory Bowel Disease - Discontinued Products (Contd..1), H2 2015 1012
Inflammatory Bowel Disease - Discontinued Products (Contd..2), H2 2015 1013
Inflammatory Bowel Disease - Discontinued Products (Contd..3), H2 2015 1014
Inflammatory Bowel Disease - Discontinued Products (Contd..4), H2 2015 1015

LIST OF FIGURES

Number of Products under Development for Inflammatory Bowel Disease, H2 2015
Number of Products under Development for Inflammatory Bowel Disease - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Assessment by Combination Products, H2 2015
Number of Products by Top 10 Targets, H2 2015
Number of Products by Stage and Top 10 Targets, H2 2015
Number of Products by Top 10 Mechanism of Actions, H2 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015
Number of Products by Top 10 Routes of Administration, H2 2015
Number of Products by Stage and Top 10 Routes of Administration, H2 2015
Number of Products by Top 10 Molecule Types, H2 2015
Number of Products by Stage and Top 10 Molecule Types, H2 2015

COMPANIES MENTIONED

4D Pharma Plc
4SC AG
AB Science SA
AbbVie Inc.
Advinus Therapeutics Ltd.
Aerpio Therapeutics, Inc.
Ajinomoto Pharmaceuticals Co., Ltd.
Akari Therapeutics, Plc
Alba Therapeutics Corporation
AlbireoPharma
Alfa Wassermann S.p.A
Allozyne, Inc.
Altheus Therapeutics, Inc.
Alvine Pharmaceuticals, Inc.
Am-Pharma B.V.
Amakem NV
Amgen Inc.
Amorepacific Corporation
Ampio Pharmaceuticals, Inc.
Amyra Biotech AG
Apogee Biotechnology Corporation
Ardelyx, Inc.
Arena Pharmaceuticals, Inc.
Argos Therapeutics, Inc.
AskAt Inc.
Astellas Pharma Inc.
Atlantic Healthcare Plc
Avaxia Biologics, Inc.
Axxam SpA
Basilea Pharmaceutica AG
BioAtla, LLC
BIOCAD
BioLineRx, Ltd.
BioLingus AG
Bionovis SA
Biotec Pharmacon ASA
BioTherapeutics Inc.
Blueberry Therapeutics Ltd
Boehringer Ingelheim GmbH
Calypso Biotech SA
Catabasis Pharmaceuticals, Inc.
Celgene Corporation
Cell2B S.A.
Cellceutix Corporation
Celltrion, Inc.
ChemoCentryx, Inc.
ChironWells GmbH
Chong Kun Dang Pharmaceutical Corp.
CLL Pharma
Commence Bio, Inc.
Cosmo Pharmaceuticals S.p.A
Creabilis SA
Cytori Therapeutics, Inc.
Daiichi Sankyo Company, Limited
DBV Technologies S.A.
Delenex Therapeutics AG
Dr. Falk Pharma GmbH
Effimune SAS
Eisai Co., Ltd.
Eli Lilly and Company
Eligo Bioscience S.A.S.
Emergent BioSolutions Inc.
Enceladus Pharmaceuticals BV
enGene, Inc
Enterome Bioscience SA
Enzo Biochem, Inc.
Epirus Biopharmaceuticals, Inc.
F. Hoffmann-La Roche Ltd.
Ferring International Center S.A.
FibroGen, Inc.
Flexion Therapeutics, Inc.
Galapagos NV
Genentech, Inc.
Genfit SA
Genor BioPharma Co., Ltd.
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Glenmark Pharmaceuticals Ltd.
GlycoMar Limited
GW Pharmaceuticals Plc
iCo Therapeutics Inc.
Idera Pharmaceuticals, Inc.
Immune Response BioPharma, Inc.
ImmusanT, Inc.
Inbiopro Solutions Pvt. Ltd.
InDex Pharmaceuticals AB
Innate Pharma SA
Innovate Biopharmaceuticals, Inc.
Innovent Biologics, Inc.
INOXIA Lifesciences GmbH
Intas Pharmaceuticals Ltd.
Intrexon Corporation
Invion Limited
Jenrin Discovery, Inc.
Johnson & Johnson
Jyant Technologies, Inc.
Kaken Pharmaceutical Co., Ltd.
Kezar Life Sciences, Inc.
Kineta, Inc.
Kymab Limited
Kyorin Pharmaceutical Co., Ltd.
Kytogenics Pharmaceuticals, Inc.
La Jolla Pharmaceutical Company
Lead Pharma Holding B.V.
LIPID THERAPEUTICS GmbH
Lpath, Inc.
LTT Bio-Pharma Co., Ltd.
Lycera Corp.
Mabion SA
Mabtech Limited
Medestea Research & Production S.p.A.
Medgenics Inc.
MedImmune, LLC
Merck & Co., Inc.
Mesoblast Limited
MetrioPharm AG
Mitsubishi Tanabe Pharma Corporation
Momenta Pharmaceuticals, Inc.
Morphotek, Inc.
Mycenax Biotech Inc.
Neovacs SA
Nivalis Therapeutics, Inc.
Novozymes A/S
Ocata Therapeutics, Inc.
Omni Bio Pharmaceutical Inc.
Oncobiologics, Inc.
Oncodesign SA
Opsona Therapeutics Limited
Otsuka Holdings Co., Ltd.
Palatin Technologies, Inc.
Pepscan Therapeutics
Pfenex Inc.
Pfizer Inc.
Plexxikon Inc.
Pluristem Therapeutics Inc.
Principia Biopharma Inc.
ProtAb Ltd
Protagonist Therapeutics Inc.
Protalix BioTherapeutics, Inc.
Provid Pharmaceuticals, Inc.
Qu Biologics Inc.
Rebiotix Inc.
Receptos, Inc.
RedHill Biopharma Ltd.
ReveraGen BioPharma, Inc.
Salix Pharmaceuticals Ltd.
Sandoz International GmbH
Saniona AB
Sanofi
Sareum Holdings Plc
SATT Nord
Selexys Pharmaceuticals Corporation
Seres Therapeutics, Inc.
Sigmoid Pharma Limited
Sitari Pharmaceuticals, Inc.
Soligenix, Inc.
Spherium Biomed S.L.
Stelic Institute & Co.
Sterna biologicals Gmbh & Co KG
Sucampo Pharmaceuticals, Inc.
Swecure AB
Sylentis S.A.
Synergy Pharmaceuticals, Inc.
Synovo GmbH
TaiwanJ Pharmaceuticals Co., Ltd.
Takeda Pharmaceutical Company Limited
Teva Pharmaceutical Industries Limited
Therapeutic Proteins International, LLC
Therapix Biosciences Ltd
Theravance Biopharma, Inc.
Tillotts Pharma AG
Tiziana
Tolerys SA
Toray Industries, Inc.
Torrent Pharmaceuticals Limited
Trino Therapeutics Limited
UCB S.A.
Upsher-Smith Laboratories, Inc.
Ventria Bioscience
VG Life Sciences, Inc.
Virobay Inc.
Vitae Pharmaceuticals, Inc.
vTv Therapeutics LLC
Winston Pharmaceuticals, Inc.
Xbrane Bioscience AB
Zedira GmbH
Zyngenia, Inc.
Skip to top


Ask Your Question

Inflammatory Bowel Disease - Pipeline Review, H2 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: